The reported statements, read against the company's own industry.
Financials view
Market Capitalization
150.64BINR
1.60B · vs all stocks (USD)
Updated Oct 29, 2026
Trailing P/E
102.49x
vs Medical Instruments & Supplies peers
Updated Oct 29, 2026
Revenue (TTM)
22.07BINR
234.81M · vs all stocks (USD)
Updated Oct 29, 2026
Profit Margin
6.72%
vs Medical Instruments & Supplies peers
Updated Oct 29, 2026
52-Week Change
-8.43%
vs all stocks
Updated Oct 29, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 29, 2026
Market Capitalization
150.64BINR
1.60B · vs all stocks (USD)
Updated Oct 29, 2026
Enterprise Value
159.33BINR
1.70B · vs all stocks (USD)
Updated Oct 29, 2026
Trailing P/E
102.49x
vs Medical Instruments & Supplies peers
Updated Oct 29, 2026
Forward P/E
56.61x
vs Medical Instruments & Supplies peers
Updated Oct 29, 2026
PEG Ratio
2.03x
vs Medical Instruments & Supplies peers
Updated Oct 29, 2026
Price to Sales (TTM)
6.85x
vs Medical Instruments & Supplies peers
Updated Oct 29, 2026
Price to Book (MRQ)
7.45x
vs Medical Instruments & Supplies peers
Updated Oct 29, 2026
Enterprise to Revenue
7.22x
vs Medical Instruments & Supplies peers
Updated Oct 29, 2026
Enterprise to EBITDA
31.72x
vs Medical Instruments & Supplies peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 26.33×.Updated Oct 29, 2026
Gross Margin
64.43%
vs Medical Instruments & Supplies peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 43.61%.Updated Oct 29, 2026
Profit Margin
6.72%
vs Medical Instruments & Supplies peers
Updated Oct 29, 2026
Operating Margin
15.00%
vs Medical Instruments & Supplies peers
Updated Oct 29, 2026
Return on Assets (TTM)
3.38%
vs Medical Instruments & Supplies peers
Updated Oct 29, 2026
Return on Equity (TTM)
6.28%
vs Medical Instruments & Supplies peers
Updated Oct 29, 2026
Revenue (TTM)
22.07BINR
234.81M · vs all stocks (USD)
Updated Oct 29, 2026
Revenue per Share (TTM)
69.76INRUpdated Oct 29, 2026
Quarterly Revenue Growth
26.00%
vs Medical Instruments & Supplies peers
Updated Oct 29, 2026
Gross Profit (TTM)
9.62BINR
102.40M · vs all stocks (USD)
Updated Oct 29, 2026
EBITDA (TTM)
6.05BINR
64.38M · vs all stocks (USD)
Updated Oct 29, 2026
Net Income (TTM)
1.48BINR
15.79M · vs all stocks (USD)
Updated Oct 29, 2026
Quarterly Earnings Growth (YoY)
50.50%
vs Medical Instruments & Supplies peers
Updated Oct 29, 2026
Operating Cash Flow (TTM)
5.19BINR
55.23M · vs all stocks (USD)
Updated Oct 29, 2026
Levered Free Cash Flow (TTM)
1.33BINR
14.17M · vs all stocks (USD)
Updated Oct 29, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 29, 2026
Trailing Annual Dividend Rate
0.00INRUpdated Oct 29, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 29, 2026
Payout Ratio
0.00%
vs Medical Instruments & Supplies peers
Updated Oct 29, 2026
Minority Interest (Equity)
942.40MINRFY2026 · Mar 31, 2026
Revenue
20.77BINRFY2026 · Mar 31, 2026
Cost of Goods Sold
11.27BINRFY2026 · Mar 31, 2026
Gross Profit
9.51BINRFY2026 · Mar 31, 2026
Operating Income
3.07BINR
32.67M · vs all stocks (USD)
FY2026 · Mar 31, 2026
Pre-tax Income
2.49BINRFY2026 · Mar 31, 2026
Income Tax Expense
805.00MINRFY2026 · Mar 31, 2026
Net Income
1.68BINRFY2026 · Mar 31, 2026
EBIT
3.39BINRFY2026 · Mar 31, 2026
EBITDA (Income Statement)
6.05BINRFY2026 · Mar 31, 2026
Selling, General & Administrative
1.36BINRFY2026 · Mar 31, 2026
Other Operating Expenses
1.76BINRFY2026 · Mar 31, 2026
Non-operating Interest Income
122.20MINRFY2026 · Mar 31, 2026
Non-operating Interest Expense
903.40MINRFY2026 · Mar 31, 2026
EPS (Basic)
4.21INRFY2026 · Mar 31, 2026
EPS (Diluted)
4.18INRFY2026 · Mar 31, 2026
Basic Shares Outstanding
316.32MSharesFY2026 · Mar 31, 2026
Diluted Shares Outstanding
316.32MSharesFY2026 · Mar 31, 2026
Minority Interests (P&L)
-349.50MINRFY2026 · Mar 31, 2026
Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026
Operating Cash Flow
2.57BINRFY2026 · Mar 31, 2026
Free Cash Flow
2.56BINRFY2026 · Mar 31, 2026
Cash & Cash Equivalents (End of Period)
905.50MINRFY2026 · Mar 31, 2026
Starting Profit (CF Statement)
2.49BINRFY2026 · Mar 31, 2026
Stock-based Compensation
73.90MINRFY2026 · Mar 31, 2026
Other Non-cash Items
776.10MINRFY2026 · Mar 31, 2026
Change in Accounts Receivable (CF)
-541.20MINRFY2026 · Mar 31, 2026
Change in Other Assets/Liabilities
-221.90MINRFY2026 · Mar 31, 2026
Capital Expenditures
8.60MINRFY2026 · Mar 31, 2026
Net Acquisitions
-913.40MINRFY2026 · Mar 31, 2026
Net Investing Cash Flow
-904.80MINRFY2026 · Mar 31, 2026
Long-term Debt Issuance
0.00INRFY2026 · Mar 31, 2026
Long-term Debt Payments
-896.00MINRFY2026 · Mar 31, 2026
Common Dividends Paid
-10.90MINRFY2026 · Mar 31, 2026
Net Financing Cash Flow
-793.20MINRFY2026 · Mar 31, 2026
Shares Outstanding
317.04MSharesUpdated Oct 29, 2026
Float Shares
120.99MSharesUpdated Oct 29, 2026
% Held by Insiders
62.83%
vs all stocks
Updated Oct 29, 2026
% Held by Institutions
29.44%
vs all stocks
Updated Oct 29, 2026
Total Cash (MRQ)
2.84BINR
30.19M · vs all stocks (USD)
Updated Oct 29, 2026
Total Cash per Share (MRQ)
8.96INRUpdated Oct 29, 2026
Total Debt (MRQ)
10.66BINR
113.45M · vs all stocks (USD)
Updated Oct 29, 2026
Total Debt to Equity (MRQ)
0.5030x
vs Medical Instruments & Supplies peers
Updated Oct 29, 2026
Current Ratio (MRQ)
1.24x
vs Medical Instruments & Supplies peers
Updated Oct 29, 2026
Book Value per Share (MRQ)
63.93INRUpdated Oct 29, 2026
Total Assets
39.42BINR
419.44M · vs all stocks (USD)
FY2026 · Mar 31, 2026
Total Current Assets
5.73BINRFY2026 · Mar 31, 2026
Total Liabilities
18.22BINRFY2026 · Mar 31, 2026
Total Non-current Assets
33.69BINRFY2026 · Mar 31, 2026
Total Non-current Liabilities
13.61BINRFY2026 · Mar 31, 2026
Total Current Liabilities
4.61BINRFY2026 · Mar 31, 2026
Cash & Cash Equivalents
905.50MINRFY2026 · Mar 31, 2026
Other Short-term Investments
2.04BINRFY2026 · Mar 31, 2026
Accounts Receivable
1.61BINRFY2026 · Mar 31, 2026
Inventory
940.30MINRFY2026 · Mar 31, 2026
Accounts Payable
1.49BINRFY2026 · Mar 31, 2026
Short-term Debt
1.15BINRFY2026 · Mar 31, 2026
Other Current Liabilities
287.90MINRFY2026 · Mar 31, 2026
Long-term Debt
9.51BINRFY2026 · Mar 31, 2026
Common Stock (Book)
316.80MINRFY2026 · Mar 31, 2026
Total Shareholders' Equity
21.20BINR
225.56M · vs all stocks (USD)
FY2026 · Mar 31, 2026
52-Week Low
401.00INRUpdated Oct 29, 2026
52-Week High
567.75INRUpdated Oct 29, 2026
52-Week Change
-8.43%
vs all stocks
Updated Oct 29, 2026
50-Day MA
493.94INRUpdated Oct 29, 2026
200-Day MA
468.31INRUpdated Oct 29, 2026
Avg 10-Day Volume
152.57KSharesUpdated Oct 29, 2026
Avg 30-Day Volume
224.05KSharesUpdated Oct 29, 2026
Diluted EPS (TTM)
4.65INRUpdated Oct 29, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Revenue has grown steadily, and the cash arriving matches reported profit.
Reads
Is this company growing?
Multi-Year Revenue And Profit Growth
Revenue and earnings have both grown steadily across six years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.64Profit Margin: 0.07
Financial Health
Altman Z-Score 5.8: safe zoneNotable
Altman Z-Score: 5.80
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $1.6B, above the global median of $1.14BNotable
Market cap (USD): 1,602,998,924.419Global Median: 1,137,180,293.291
Companies that share the same coordination system — how they create, deliver, or capture value.